Cargando…
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
Breast cancer brain metastases (BCBM) are detected with increasing incidence. In order to detect potential genes involved in BCBM, we first screened for genes down-regulated by methylation in cell lines with site-specific metastatic ability. The expression of five genes, CADM1, SPARC, RECK, TNFAIP3...
Autores principales: | Wikman, Harriet, Westphal, Laura, Schmid, Felicitas, Pollari, Sirkku, Kropidlowski, Jolanthe, Sielaff-Frimpong, Bettina, Glatzel, Markus, Matschke, Jakob, Westphal, Manfred, Iljin, Kristiina, Huhtala, Heini, Terracciano, Luigi, Kallioniemi, Anne, Sauter, Guido, Müller, Volkmar, Witzel, Isabell, Lamszus, Katrin, Kemming, Dirk, Pantel, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102793/ https://www.ncbi.nlm.nih.gov/pubmed/24833255 |
Ejemplares similares
-
Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012) -
Clonality of circulating tumor cells in breast cancer brain metastasis patients
por: Riebensahm, Carlotta, et al.
Publicado: (2019) -
PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial‐mesenchymal transition in cultured breast cancer cells
por: Lehtinen, Laura, et al.
Publicado: (2017) -
Relevance of PTEN loss in brain metastasis formation in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2012) -
Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients
por: Leffers, Markus, et al.
Publicado: (2022)